Reference
[Please submit your publication]
|
Park J, Lee J, Kim JH, Lee J, Park H, Lim C. ZNF598 co-translationally titrates poly(GR) protein implicated in the pathogenesis of C9ORF72-associated ALS/FTD. Nucleic Acids Res (2021) 49(19) 11294-11311
[
PubMed ID = 34551427
]
[
RRC reference
]
Rauskolb C, Pan G, Reddy BV, Oh H, Irvine KD. Zyxin links fat signaling to the hippo pathway. PLoS Biol (2011) 9(6) e1000624
[
PubMed ID = 21666802
]
[
RRC reference
]
|
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
482 |
10 |
4 |
10 |
NM_132678.2 |
CG2691-RA (CG2691), mRNA |
0.41 |
2 |
3 |
3 |
2 |
NM_169854.1 |
CG31212-RA (CG31212), mRNA |
0 |
0 |
5 |
2 |
3 |
NM_142585.1 |
CG4733-RA (CG4733), mRNA |
0 |
0 |
3 |
4 |
13 |
NM_142078.1 |
CG12402-RA (CG12402), mRNA |
0 |
0 |
2 |
5 |
8 |
NM_078977.2 |
CG10897-RA, transcript variant A (tou), mRNA |
0 |
0 |
2 |
4 |
2 |
NM_140625.2 |
CG4818-RA (CG4818), mRNA |
0 |
0 |
2 |
2 |
5 |
NM_206294.1 |
CG33275-RA, transcript variant A (CG33275), mRNA |
0 |
0 |
2 |
2 |
5 |
NM_206295.1 |
CG33275-RB, transcript variant B (CG33275), mRNA |
0 |
0 |
2 |
2 |
4 |
NM_206099.1 |
CG8878-RB, transcript variant B (CG8878), mRNA |
0 |
0 |
2 |
2 |
4 |
NM_136889.2 |
CG8878-RA, transcript variant A (CG8878), mRNA |
0 |
0 |
2 |
2 |
1 |
NM_137618.1 |
CG9864-RA (CG9864), mRNA |
0 |
0 |
1 |
5 |
4 |
NM_135642.2 |
CG6181-RA, transcript variant A (CG6181), mRNA |
0 |
0 |
1 |
5 |
4 |
NM_164957.1 |
CG6181-RB, transcript variant B (CG6181), mRNA |
0 |
0 |
1 |
5 |
3 |
NM_132130.1 |
CG12796-RA (CG12796), mRNA |
0 |
0 |
1 |
5 |
2 |
NM_078583.2 |
CG2559-RA (Lsp1alpha), mRNA |
0 |
0 |
1 |
4 |
2 |
NM_080012.2 |
CG4201-RA (ird5), mRNA |
0 |
0 |
1 |
3 |
3 |
NM_137927.1 |
CG9871-RA (CG9871), mRNA |
0 |
0 |
1 |
3 |
2 |
NM_001014582.1 |
CG10488-RB, transcript variant B (eyg), mRNA |
0 |
0 |
1 |
3 |
2 |
NM_079318.2 |
CG10488-RA, transcript variant A (eyg), mRNA |
0 |
0 |
1 |
2 |
8 |
NM_141157.2 |
CG11238-RA (l(3)04053), mRNA |
0 |
0 |
1 |
2 |
5 |
NM_057701.3 |
CG5820-RD, transcript variant D (Gp150), mRNA |
0 |
0 |
1 |
2 |
5 |
NM_166529.1 |
CG5820-RC, transcript variant C (Gp150), mRNA |
0 |
0 |
1 |
2 |
5 |
NM_166528.1 |
CG5820-RB, transcript variant B (Gp150), mRNA |
0 |
0 |
1 |
2 |
5 |
NM_166527.1 |
CG5820-RA, transcript variant A (Gp150), mRNA |
0 |
0 |
1 |
2 |
2 |
NM_176104.1 |
CG33087-RC (CG33087), mRNA |
0 |
0 |
0 |
8 |
5 |
NM_131939.4 |
CG17592-RB, transcript variant B (Usf), mRNA |
0 |
0 |
0 |
8 |
5 |
NM_167010.1 |
CG17592-RA, transcript variant A (Usf), mRNA |
0 |
0 |
0 |
8 |
5 |
NM_139839.3 |
CG32381-RA (unc-13-4A), mRNA |
0 |
0 |
0 |
7 |
35 |
NM_143342.1 |
CG5514-RB, transcript variant B (CG5514), mRNA |
0 |
0 |
0 |
7 |
35 |
NM_170361.1 |
CG5514-RA, transcript variant A (CG5514), mRNA |
|